Mustafa NAMIDURU, Ayşe Özlem METE, Vuslat BOŞNAK, Saliha ÇEVİK, İlkay KARAOĞLAN

Invasive device-associated hospital infection rates, etiological agents, and their antibiotic susceptibilities in the medical intensive care unit of a university hospital in Turkey

To determine the rate, etiological agents, antibiotic susceptibilities, and empirical treatment options of etiological agents of invasive device-associated hospital infections (IDAHIs) in the medical intensive care unit of a university hospital. Materials and methods: Between February 2007 and December 2009, 780 IDAHI cases were evaluated in 1650 patients. Results: Ventilator associated pneumonia, catheter-associated urinary tract infection, and central venous catheter-associated blood stream infection were observed in 415, 242, and 143 IDAHI cases, respectively. The most frequently isolated etiological agents were Acinetobacter spp. in ventilator-associated pneumonia, coagulase-negative staphylococci (CoNS) in central venous catheter-associated blood stream infection, and Candida spp. and E. coli in catheter-associated urinary tract infection. Conclusion: In our study, oxacillin resistance in coagulase-positive S. aureus and CoNS was high. Glycopeptides and linezolid should be considered as treatment options. Resistance of enteric bacteria is defined high against cephalosporin, aminoglycoside, and quinolone. Carbapenems can be considered in the empirical treatment of enteric bacterial infections. Colistin can be given in the treatment of resistant Acinetobacter infections as a therapeutic option. Since antifungal resistance is low, fluconazole should be the first drug of choice in the treatment of candidal infections.

Anahtar Kelimeler:

Key words: Intensive care unit, invasive devices, antibiotic susceptibilities, nosocomial infections, surveillance

Invasive device-associated hospital infection rates, etiological agents, and their antibiotic susceptibilities in the medical intensive care unit of a university hospital in Turkey

Keywords:

Key words: Intensive care unit, invasive devices, antibiotic susceptibilities, nosocomial infections, surveillance,

PDF

___

Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309–32.
Dizbay M, Bas S, Gursoy A, Simşek H, Maral I, Aktas F. Invasive device-related infection surveillance in intensive care units of Gazi University Hospital in 2006–2007. Türkiye Klinikleri Journal of Medical Sciences 2009; 29: 140–5.
Candevir A, Kurtaran B, Kibar F, Karakoç E, Aksu HSZ, Taşova Y. Invasive device-associated nosocomial infections of a teaching hospital in Turkey; four years’ experience. Turk J Med Sci 2011; 41: 137–147.
Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ et al. Device-associated infections rates and mortality in intensive care units of Peruvian Hospitals. International Nosocomial Infection Control Consortium (INICC) findings. Pan American Journal of Public Health 2008; 24: 16–24. Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infection Control and Hospital Epidemiology 2006; 27: 349–56.
Leblebicioğlu H, Rosenthal VD, Arıkan OA, Özgültekin A, Yalcin AN, Köksal I et al. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007; 65: 251–7.
Jain R, Danziger LH. Multidrug-resistant acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 2004; 38: 1449–59.